Valuation: DiaSorin S.p.A.

Market Cap 3.78B 4.36B 3.53B 3.23B 6.08B 416B 6.17B 41.39B 16.24B 208B 16.38B 16.02B 693B P/E 2026 *
21.9x
P/E 2027 * 19.3x
Enterprise Value 4.47B 5.17B 4.18B 3.82B 7.2B 493B 7.31B 49.03B 19.24B 247B 19.4B 18.98B 821B EV / Sales 2026 *
3.62x
EV / Sales 2027 * 3.29x
Free-Float
37.17%
Yield 2026 *
1.71%
Yield 2027 * 1.8%
1 day-0.37%
1 week+2.01%
Current month+5.76%
1 month+9.38%
3 months+13.94%
6 months+2.65%
Current year+10.75%
1 week 73.84
Extreme 73.84
76.46
1 month 63
Extreme 63
76.46
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
08/01/26 Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+2.01%-7.86%-16.94% 4.36B
-0.75%+5.28%+208.33%+363.44% 22.44B
-0.14%+0.83%-41.25%-22.08% 9.97B
+12.57%+24.59%+376.57%+12.83% 7.63B
+2.90%+43.38%-21.34% - 6.61B
+0.03%-0.21%+76.54%+48.30% 6.59B
+1.51%+2.23%-10.99%-12.48% 5.71B
-0.47%+11.80%+82.30%+104.76% 4.49B
+1.30%-3.86%-19.78%-35.33% 2.78B
+0.45%+27.80%+117.37%+236.51% 1.43B
Average +1.70%+51.93%+75.99%+75.45% 7.2B
Weighted average by Cap. +1.48%+83.15%+109.51%+136.34%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.15B 1.05B 1.99B 136B 2.02B 13.53B 5.31B 68.03B 5.35B 5.24B 227B 1.31B 1.51B 1.22B 1.12B 2.11B 144B 2.14B 14.36B 5.64B 72.23B 5.68B 5.56B 241B
Net income 181M 209M 169M 154M 291M 19.89B 295M 1.98B 777M 9.95B 783M 766M 33.14B 205M 237M 192M 176M 331M 22.64B 336M 2.25B 884M 11.33B 891M 872M 37.72B
Net Debt 697M 805M 652M 596M 1.12B 76.82B 1.14B 7.64B 3B 38.43B 3.02B 2.96B 128B 539M 622M 504M 460M 867M 59.36B 881M 5.91B 2.32B 29.7B 2.34B 2.29B 98.91B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,260
Date Price Change Volume
11/08/26 76.00 -0.37% 55,887
10/08/26 €76.28 +1.17% 141,673
07/08/26 €75.40 +1.26% 251,852
06/08/26 €74.46 -0.61% 118,192
05/08/26 €74.92 +0.56% 132,598
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
76.28EUR
Average target price
72.45EUR
Spread / Average Target
-5.02%

Quarterly revenue - Rate of surprise